UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Journal of dermatological science, 2016-03, Vol.81 (3), p.153-164

2016

Volltextzugriff (PDF)

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Journal of the American Academy of Dermatology, 2021-07, Vol.85 (1), p.71-78

2021

Volltextzugriff (PDF)

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

Journal of dermatological science, 2014-08, Vol.75 (2), p.133-139

2014

Volltextzugriff (PDF)

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.3335-3337.e1

2022

Volltextzugriff (PDF)

Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis

Journal of dermatological science, 2017-12, Vol.88 (3), p.330-338

2017

Volltextzugriff (PDF)

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Journal of the American Academy of Dermatology, 2023-04, Vol.88 (4), p.816-823

2023

Volltextzugriff (PDF)

Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy

Archives of Dermatological Research, 2014-10, Vol.306 (8), p.719-729

2014

Volltextzugriff (PDF)

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Journal of drugs in dermatology, 2013-08, Vol.12 (8), p.e129

2013

Volltextzugriff (PDF)

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

Journal of dermatological science, 2017-02, Vol.85 (2), p.147-147

2017

Volltextzugriff (PDF)

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Anticancer research, 2014-12, Vol.34 (12), p.7207-7217

2014

Volltextzugriff (PDF)

Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model

Journal of translational medicine, 2009-12, Vol.7 (1), p.107-107, Article 107

2009

Volltextzugriff (PDF)

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.957-958

2014

Volltextzugriff (PDF)

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

Dermatitis, 2015-07, Vol.26 (4), p.195-196

2015

Volltextzugriff (PDF)

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB198-AB198

2023

Volltextzugriff (PDF)

Objective Quantification of Immune Cell Infiltrates and Epidermal Proliferation in Psoriatic Skin: A Comparison of Digital Image Analysis and Manual Counting

Applied immunohistochemistry & molecular morphology, 2016-07, Vol.24 (6), p.453-458

2016

Volltextzugriff (PDF)

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB92-AB92

2023

Volltextzugriff (PDF)

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB241-AB241

2023

Volltextzugriff (PDF)

Psoriasis drug discovery: methods for evaluation of potential drug candidates

Expert opinion on drug discovery, 2012-01, Vol.7 (1), p.49-61

2012

Volltextzugriff (PDF)

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB177-AB177

2021

Volltextzugriff (PDF)

In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin

Journal of biomedical optics, 2017-07, Vol.22 (7), p.076018-076018

2017

Volltextzugriff (PDF)

Key immune modulatory effects exerted by combination of calcipotriol and corticosteroid on psoriasis inflammation

Journal of dermatological science, 2016-10, Vol.84 (1), p.e102-e103

2016

Volltextzugriff (PDF)

Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère

Annales de Dermatologie et de Vénéréologie - FMC, 2023-12, Vol.3 (8), p.A61

2023

Volltextzugriff (PDF)

Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis

Skin (Milwood, N.Y.), 2024-01, Vol.8 (1), p.s324

2024

Volltextzugriff (PDF)

Spontaneous Human Squamous Cell Carcinomas are Killed by a Human Cytotoxic T Lymphocyte Clone Recognizing a Wild-Type p53-Derived Peptide

Proceedings of the National Academy of Sciences - PNAS, 1996-12, Vol.93 (25), p.14704-14707

1996

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)
Buchkapitel
(2)

Sprache

Englisch
(36)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Humans
(18)
Dermatology
(11)
Animals
(8)
Psoriasis
(5)
Psoriasis - Drug Therapy
(5)
Psoriasis - Pathology
(5)
Betamethasone - Analogs & Derivatives
(4)
Betamethasone - Pharmacology
(4)
Calcitriol - Analogs & Derivatives
(4)
Cells, Cultured
(4)
Female
(4)
Micrornas - Genetics
(4)
Rabbits
(4)
Skin - Drug Effects
(4)
Skin - Metabolism
(4)
Adult
(3)
Betamethasone - Administration & Dosage
(3)
Biochemistry & Molecular Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Objective Quantification of Immune Cell Infiltrates and Epidermal Proliferation in Psoriatic Skin: A Comparison of Digital Image Analysis and Manual Counting

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

Psoriasis drug discovery: methods for evaluation of potential drug candidates

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin

Key immune modulatory effects exerted by combination of calcipotriol and corticosteroid on psoriasis inflammation

Le tralokinumab module le profil transcriptomique de la peau (lésionnelle ou non) chez les adolescents atteints de dermatite atopique modérée à sévère

Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis

Spontaneous Human Squamous Cell Carcinomas are Killed by a Human Cytotoxic T Lymphocyte Clone Recognizing a Wild-Type p53-Derived Peptide

Aktive Filter

Suchergebnisse filtern